메뉴 건너뛰기




Volumn 3, Issue 3, 2010, Pages 45-53

Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial

Author keywords

Cancer; Epoetin Beta; Epoetin Theta; Placebo; Symptomatic Anaemia

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HEMOGLOBIN; IRON; PLACEBO; PLATINUM DERIVATIVE; RECOMBINANT ERYTHROPOIETIN;

EID: 78851470523     PISSN: None     EISSN: 17535174     Source Type: Journal    
DOI: 10.1111/j.1753-5174.2010.00030.x     Document Type: Article
Times cited : (20)

References (9)
  • 1
    • 0023120533 scopus 로고
    • Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial
    • Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial. N Engl J Med 1987;316:73-8.
    • (1987) N Engl J Med , vol.316 , pp. 73-78
    • Eschbach, J.W.1    Egrie, J.C.2    Downing, M.R.3    Browne, J.K.4    Adamson, J.W.5
  • 2
    • 0022980521 scopus 로고
    • Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis
    • Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986;2:1175-8.
    • (1986) Lancet , vol.2 , pp. 1175-1178
    • Winearls, C.G.1    Oliver, D.O.2    Pippard, M.J.3    Reid, C.4    Downing, M.R.5    Cotes, P.M.6
  • 3
    • 0028793205 scopus 로고
    • Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: Dose finding and identification of predictors of response
    • Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, etal. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: Dose finding and identification of predictors of response. Blood 1995;86:4446-53.
    • (1995) Blood , vol.86 , pp. 4446-4453
    • Cazzola, M.1    Messinger, D.2    Battistel, V.3    Bron, D.4    Cimino, R.5    Enller-Ziegler, L.6
  • 4
    • 0037719383 scopus 로고    scopus 로고
    • Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production
    • Cazzola M, Beguin Y, Kloczko J, Spicka I, Coiffier B. Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production. Br J Haematol 2003;122:386-93.
    • (2003) Br J Haematol , vol.122 , pp. 386-393
    • Cazzola, M.1    Beguin, Y.2    Kloczko, J.3    Spicka, I.4    Coiffier, B.5
  • 5
    • 2142858255 scopus 로고    scopus 로고
    • Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy
    • Granetto C, Ricci S, Martoni A, Pezzella G, Testore F, Mattioli R, etal. Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy. Oncol Rep 2003;10:1289-96.
    • (2003) Oncol Rep , vol.10 , pp. 1289-1296
    • Granetto, C.1    Ricci, S.2    Martoni, A.3    Pezzella, G.4    Testore, F.5    Mattioli, R.6
  • 6
    • 5344245985 scopus 로고    scopus 로고
    • EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer
    • Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, etal. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 2004;40:2201-16.
    • (2004) Eur J Cancer , vol.40 , pp. 2201-2216
    • Bokemeyer, C.1    Aapro, M.S.2    Courdi, A.3    Foubert, J.4    Link, H.5    Osterborg, A.6
  • 7
    • 0030755786 scopus 로고    scopus 로고
    • The functional assessment of cancer therapy-anaemia (FACT-AN) scale: A new tool for the assessment of outcomes in cancer anaemia and fatigue
    • Cella D. The functional assessment of cancer therapy-anaemia (FACT-AN) scale: A new tool for the assessment of outcomes in cancer anaemia and fatigue. Semin Hematol 1997;34:13-9.
    • (1997) Semin Hematol , vol.34 , pp. 13-19
    • Cella, D.1
  • 8
    • 78851469032 scopus 로고    scopus 로고
    • European Medicines Agency. EMEA Public statement: European medicines agency starts review of the safety of epoetins. Doc.Ref. EMEA/188068/2007-corr. London, 27 April 2007.
    • EMEA Public statement: European medicines agency starts review of the safety of epoetins. Doc.Ref. EMEA/188068/2007-corr. London, 27 April 2007.
  • 9
    • 33645334937 scopus 로고    scopus 로고
    • Cancer-related anemia and recombinant human erythropoietin-An updated overview
    • Bohlius J, Weingart O, Trelle S, Engert A. Cancer-related anemia and recombinant human erythropoietin-An updated overview. Nat Clin Pract Oncol 2006;3:152-64.
    • (2006) Nat Clin Pract Oncol , vol.3 , pp. 152-164
    • Bohlius, J.1    Weingart, O.2    Trelle, S.3    Engert, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.